February 28, 2015 |
"Did I just die?" Those pretty much are the last words you want to hear from your lover. Especially if she's as lovely as Olivia Wilde. That's one of the many unintentionally funny lines in The Lazarus Effect , a creepy thriller that boasts a fine cast, including Mark Duplass, Donald Glover, Sarah Bolger, and Evan Peters, and one of the most derivative scripts this side of the Scary Movie franchise. Mildly enjoyable despite its basic mediocrity, The Lazarus Effect stars Wilde and Duplass as brilliant research scientists and lovers, named Zoe and Frank who have developed a life-giving serum that can bring the dead to life - just as the slimy fluorescent green stuff did in one of the film's chief inspirations, Re-Animator . (Actually, the couple didn't so much invent the drug as borrow it from the TV show Smallville , where the term Lazarus Serum originated.)
October 11, 2013
ALL Ralph, no Alice. That's been the problem the past couple of decades with our "Honeymooners" economy, except that no one who wants a good job thinks it's funny. "The Honeymooners," for you kids out there, is a classic TV show whose characters formed the basis for the modern sitcom: Ralph Kramden, the husband who always had a dubious get-rich-quick scheme in the works, and Alice Kramden, the wife who always said no. In this, the show was on firm anthropological ground. Studies consistently show that women are better investors than men. They favor slow-and-steady growth, while men - entranced by the lure of speculative profits - ignore catastrophic risk.
April 17, 2013 |
The U.S. Supreme Court hearing Monday on whether human genes can be patented cuts to the heart of law, science, and even philosophy: Should a firm have exclusive rights to use the genetic code in your cells? Patients, researchers, and the life-sciences industry all have much at stake. But beneath the dispute lies an issue that may be more important in the long run. Who should own the aggregated information that companies compile with gene patents? The issue was not raised in the hour-long hearing Monday before the court, but it's critical.
December 21, 2012 |
Tom Hayes, one of two former UBS AG traders charged by U.S. prosecutors, is portrayed by American regulators as the kingpin of a three-year campaign that succeeded in manipulating global interest rates. Hayes, 33, was charged with wire fraud and price-fixing, the Department of Justice said in a criminal complaint unsealed Wednesday. The trader and Roger Darin, a former short-term interest-rates trader at UBS whose responsibilities included the firm's Libor quotes in yen, were also charged with conspiracy.
April 9, 2012 |
By Eric Posner and Glen Weyl In February, Mary Schapiro, chairwoman of the Securities and Exchange Commission, said the agency is looking for ways to rein in high-frequency traders, who use computer algorithms to buy and sell derivatives at lightning speed to make instantaneous profits. High-speed trading can waste resources and disrupt markets, so the commission is right to look into it. But this is only one issue at the edge of a bigger problem requiring significant government intervention.
November 18, 2011 |
JPMorgan Chase & Co. and Goldman Sachs Group Inc., among the world's biggest traders of credit derivatives, have disclosed to shareholders that they have sold protection on more than $5 trillion of debt globally. Just don't ask them how much of that was issued by Greece, Italy, Ireland, Portugal, and Spain, sometimes known as the GIIPS, or even PIIGS. As concerns mount that those countries may not be creditworthy, investors are being kept in the dark about how much risk U.S. banks face from a default.
November 11, 2011 |
NEW YORK - Defunct trading company MF Global Inc. has terminated its entire workforce of 1,066 employees, the trustee for its liquidation said Friday. James W. Giddens, the court-appointed trustee for the liquidation of MF Global, said in a statement that the company is dismissing workers in accordance with a bankruptcy court mandate. Between 150 and 200 former employees are being hired to assist with the liquidation and court proceedings. The company did not specify which employees it will rehire, presumably on a temporary basis, to help conduct the liquidation.
October 17, 2011
Federal prosecutors have alleged that some California dispensers of medical marijuana are peddling their product to recreational users. Meanwhile, a medical-marijuana program with stricter controls is getting under way in New Jersey. Now, scientists at Temple University are exploring a less controversial option: providing at least one of the purported medical benefits of pot without the high. They are looking at the properties of a marijuana extract called cannabidiol, which has anti-inflammatory and pain-relief properties but no psychoactive effects.
June 6, 2011 |
Shell Oil Co. announced Monday it is developing plans to build a large Appalachian petrochemical plant to process or "crack" ethane from Marcellus Shale natural gas. The plant's location is not yet determined, but ethane is a valuable side stream of Marcellus production in southwestern Pennsylvania and West Virginia. Ethane is processed into ethylene and derivatives such as polyethylene, a raw material in plastics. Most of the material now produced in the region is shipped to Gulf Coast petrochemical plants.
August 3, 2010
Radian Group Inc., the second-largest U.S. mortgage insurer, posted its fourth straight quarterly loss on a charge tied to derivatives. The second-quarter net loss was $475.1 million ($4.31 a share), over profit of $231.9 million ($2.82 a share) in the year-earlier period, the Philadelphia-based company said in a statement today. Excluding results from the derivatives, the loss was $1.22 a share, wider than the 78-cent loss that was the average estimate of seven analysts surveyed by Bloomberg.